Nutritional and dietary aspects in polycystic ovary syndrome: insights into the biology of nutritional interventions

References

• Arch WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–551.
   PubMed Web of Science ®Google Scholar
• Shaaban Z, Khoradmehr A, Jafarzadeh Shirazi MR, et al. Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome. Iran J Basic Med Sci. 2019;22(1):3–16.
   PubMed Web of Science ®Google Scholar
• Hoeger KM. Developmental origins and future fate in PCOS. Semin Reprod Med. 2014;32(3):157.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364–379.
   PubMed Web of Science ®Google Scholar
• Gugusheff JR, Ong ZY, Muhlhausler BS. The early origins of food preferences: targeting the critical windows of development. FASEB J. 2015;29(2):365–373.
   PubMed Web of Science ®Google Scholar
• Lin AW, Lujan ME. Comparison of dietary intake and physical activity between women with and without polycystic ovary syndrome: a review. Adv Nutr. 2014;5(5):486–496.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Noakes M, Clifton PM, et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(2):812–819.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Pasquali R, Teede HJ, et al. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril. 2009;92(6):1966–1982.
   PubMed Web of Science ®Google Scholar
• Barr S, Hart K, Reeves S, et al. Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome. Eur J Clin Nutr. 2011;65(10):1126–1132.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Grieger JA, Mishra GD, et al. The association of a Mediterranean-style diet pattern with polycystic ovary syndrome status in a community cohort study. Nutrients. 2015;7(10):8553–8564.
   PubMed Web of Science ®Google Scholar
• Frigolet M-E, Ramos Barragán V-E, Tamez González M. Low-carbohydrate diets: a matter of love or hate. Ann Nutr Metab. 2011;58(4):320–334.
   PubMed Web of Science ®Google Scholar
• Douglas CC, Gower BA, Darnell BE, et al. Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril. 2006;85(3):679–688.
   PubMed Web of Science ®Google Scholar
• Panidis D, Tziomalos K, Papadakis E, et al. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Endocrine. 2013;44(3):583–590.
   PubMed Web of Science ®Google Scholar
• Tolino A, Gambardella V, Caccavale C, et al. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2005;119(1):87–93.
   PubMed Web of Science ®Google Scholar
• Accurso A, Bernstein RK, Dahlqvist A, et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab. 2008;5:9.
   Google Scholar
• Mavropoulos JC, Yancy WS, Hepburn J, et al. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab. 2005;2:35.
   Google Scholar
• Mehrabani HH, Salehpour S, Amiri Z, et al. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study. J Am Coll Nutr. 2012;31(2):117–125.
   PubMed Web of Science ®Google Scholar
• Stamets K, Taylor DS, Kunselman A, et al. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril. 2004;81(3):630–637.
   PubMed Web of Science ®Google Scholar
• de Lordes Lima M, Cruz T, Pousada JC, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998;21(5):682–686.
   PubMed Web of Science ®Google Scholar
• Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World J Diabetes. 2015;6(10):1152–1157.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Polansky MM, Bryden NA, et al. Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. Am J Clin Nutr. 1991;54(5):909–916.
   PubMed Web of Science ®Google Scholar
• Tang XL, Sun Z, Gong L. Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis. J. Obstet Gynaecol. Res. 2018;44(1):134–143.
   PubMed Web of Science ®Google Scholar
• Zheng G, Wang L, Guo Z, et al. Association of serum heavy metals and trace element concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population. Biol Trace Elem Res. 2015;167(1):1–10.
   PubMed Web of Science ®Google Scholar
• Kim J, Ahn J. Effect of zinc supplementation on inflammatory markers and adipokines in young obese women. Biol Trace Elem Res. 2014;157(2):101–106.
   PubMed Web of Science ®Google Scholar
• Guler I, Himmetoglu O, Turp A, et al. Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance. Biol Trace Elem Res. 2014;158(3):297–304.
   PubMed Web of Science ®Google Scholar
• Kilic-Okman T, Kucuk M. N-acetyl-cysteine treatment for polycystic ovary syndrome. Int J Gynaecol Obstet. 2004;85(3):296–297.
   PubMed Web of Science ®Google Scholar
• Fulghesu AM, Ciampelli M, Muzj G, et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril. 2002;77(6):1128–1135.
   PubMed Web of Science ®Google Scholar
• Steiber A, Kerner J, Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med. 2004;25(5–6):455–473.
   PubMedGoogle Scholar
• Reda E, D’Iddio S, Nicolai R, et al. The carnitine system and body composition. Acta Diabetol. 2003;40(S1):s106–s113.
   PubMedGoogle Scholar
• Fenkci SM, Fenkci V, Oztekin O, et al. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Hum Reprod. 2008;23(7):1602–1606.
   PubMed Web of Science ®Google Scholar
• Vigerust NF, Bohov P, Bjørndal B, et al. Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment. Fertil Steril. 2012;98(6):1620–1626.
   PubMed Web of Science ®Google Scholar
• Tantalaki E, Piperi C, Livadas S, et al. Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS). Hormones. 2014;13(1):65–73.
   PubMedGoogle Scholar
• Schachter M, Raziel A, Friedler S, et al. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod. 2003;18(4):721–727.
   PubMed Web of Science ®Google Scholar
• Yaralı H, Yıldırır A, Aybar F, et al. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril. 2001;76(3):511–516.
   PubMed Web of Science ®Google Scholar